03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Supreme Court Confirms When an Employee is Entitled to Legal Representation - Precedential Decision...
Read More >
On April 8, 2020, Governor Murphy signed Executive Order No. 122 (the Order) strengthening mitigatio...
Read More >
The Ballard Spahr Zoning and Land Use Team is continuing to monitor all aspects of the Philadelphia ...
Read More >
As our economy’s uptick continues to favor buyers, developers often find large parcels of contiguou...
Read More >
There is an increasing trend in legal challenges to an employer’s administration of a wellness prog...
Read More >
For certain healthcare transactions that will close on or after Jan. 1, 2020, parties to the transac...
Read More >